EichorEICHOR
Study identifier: NCT06581861 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

PREVENT ALL ALS Study

Condition: Amyotrophic Lateral Sclerosis  ·  Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

PhaseN/A
Planned participants600
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is begin funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) and managed by two clinical coordinating centers (CCC) at Barrow Neurological Institute and Massachusetts General Hospital. The clinical sites are distributed across the country, and led by a group of collaborative principal investigators. Once data and samples are collected and harmonized, it will be made available to research community for future research into ALS and related neurological diseases. PREVENT protocol is specific for asymptomatic participants who are genetically at risk for ALS. The participants will be followed for up to 36 months (3 years), and will include 4 in-person on-site visits once a year and 6 off-site(remote) visits once in 4 months. The study includes collection of medical history, clinical outcomes, and blood samples once in 4 months. Additionally, the participants will complete patient reported outcomes and speech recordings once in 4 months. Participants may also provide optional Cerebrospinal Fluid (CSF) samples.The participants may also opt into a sub-study if they are interested in genetic testing for ALS causative genes. The sub-study will involve a minimum of 3 visits over a c…

This description comes directly from the study's public registry record.

Talk to the study team

ALL ALS Patient Navigator  ·  602-845-0248  ·  info@all-als.org

Always discuss trial participation with your own doctor first.

Locations (32)

University of Alabama BirminghamBirmingham, Alabama, United StatesRecruiting
Barrow Neurological InstitutePhoenix, Arizona, United StatesRecruiting
University of California San DiegoLa Jolla, California, United StatesRecruiting
University of California IrvineOrange, California, United StatesRecruiting
University of California, San FranciscoSan Francisco, California, United StatesRecruiting
University of Colorado Anschutz Medical CampusAurora, Colorado, United StatesRecruiting
Hospital for Special CareNew Britain, Connecticut, United StatesRecruiting
Georgetown UniversityWashington D.C., District of Columbia, United StatesRecruiting
Mayo ClinicJacksonville, Florida, United StatesRecruiting
Saint Alphonsus Regional Medical CenterBoise, Idaho, United StatesRecruiting
Northwestern UniversityChicago, Illinois, United StatesRecruiting
Indiana UniversityIndianapolis, Indiana, United StatesRecruiting

+ 20 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →